文献速递冠心病外科主动脉外科

冠状动脉旁路移植术中同期升主动脉置换的安全性:STS数据库研究

Safety of Concomitant Ascending Aortic Aneurysm Repair During Coronary Artery Bypass Grafting: A Society of Thoracic Surgeons Database Study.
PubMed 文献 · Ann Thorac Surg · 2025-08-12

基于STS数据库2014至2023年择期成人CABG患者(三支病变或左主干>50%),比较同期择期升主动脉置换与单纯CABG的早期结局。经逆概率加权后,同期手术组死亡率、卒中、延长通气、肾衰竭及合并并发症/死亡率均显著更高。择期升主动脉置换在CABG中不常见,但与早期不良结局风险显著增加相关。

要点

  • 择期CABG同期升主动脉置换仅占0.2%,但早期死亡风险增加57%。
  • 同期手术组卒中风险为单纯CABG的3.2倍,延长通气风险2.25倍。
  • 合并并发症/死亡率同期手术组16.1% vs 8.3%,风险比1.94。

核心结论

  • 择期CABG同期升主动脉置换不常见,但与早期术后不良结局风险显著增加相关。
  • 这些发现可能有助于指南制定,明确择期CABG患者同期升主动脉置换的相对风险。

研究设计与样本

  • 回顾性队列研究,使用STS数据库2014至2023年择期成人CABG患者,纳入三支病变或左主干病变>50%。
  • 识别同期择期计划升主动脉置换亚组,采用逆概率治疗加权平衡混杂因素后比较结局。
  • 共纳入372,953例CABG患者和833例(0.2%)同期择期升主动脉置换患者。

主要发现

  • 同期升主动脉置换的相对风险:死亡1.57(95%CI 1.01-2.4);卒中3.2(95%CI 2.24-4.57)。
  • 延长通气2.25(95%CI 1.83-2.76);肾衰竭1.70(95%CI 1.10-2.64);合并并发症/死亡率1.94(95%CI 1.65-2.26)。

临床怎么用

  • 在择期CABG患者中考虑同期预防性升主动脉置换时,应权衡早期死亡、卒中、延长通气及肾衰竭风险显著增加。
  • 本研究结果可为指南更新提供依据,帮助明确同期升主动脉置换的相对风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The 2022 American College of Cardiology/American Heart Association aortic disease guideline recommends concomitant ascending aortic replacement at the same size criteria for all cardiac operations. We sought to determine the added risk of performing an elective prophylactic ascending aortic replacement during coronary artery bypass grafting (CABG) using The Society of Thoracic Surgeons (STS) database. METHODS: The STS database was queried for all elective adult CABG patients from 2014 to 2023 with either triple-vessel or left main disease >50%. A subgroup undergoing concomitant elective planned ascending aortic replacement was identified. Inverse probability of treatment weighting balanced confounders between the CABG and CABG/aortic groups before outcomes were compared. RESULTS: There were 372,953 CABG patients and 833 (0.2%) concomitant elective ascending aortic replacement patients identified. After inverse probability of treatment weighting, the combined aortic + CABG group had higher rates of almost all STS-reported outcomes including mortality (2.3% vs 1.5%; P = .0473), stroke (3.6% vs 1.1%; P < .0001), prolonged ventilation (9.9% vs 4.4%; P < .0001), renal failure (2.3% vs 1.4%; P = .0170), and combined morbidity and mortality (16.1% vs 8.3%; P < .0001). The relative risk of death for adding ascending aortic replacement to CABG was 1.57 (95% CI, 1.01-2.4); stroke, 3.2 (95% CI, 2.24-4.57); prolonged ventilation, 2.25 (95% CI, 1.83-2.76); renal failure, 1.70 (95% CI, 1.10-2.64); and combined morbidity/mortality, 1.94 (95% CI, 1.65-2.26). CONCLUSIONS: Elective ascending aortic replacement is not common in CABG but is associated with significantly higher risk of poor outcomes in the early postoperative period. These findings may help inform guidelines regarding the relative risk of concomitant ascending aortic replacement in elective CABG patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Salna M, Wang C, Anzai I, et al. Safety of Concomitant Ascending Aortic Aneurysm Repair During Coronary Artery Bypass Grafting: A Society of Thoracic Surgeons Database Study. Ann Thorac Surg. 2025. PMID: 40812764. doi:10.1016/j.athoracsur.2025.07.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。